7779 Stock Overview
Researches, develops, produces, sell, leases, and maintains equipment and systems for medical and warfare in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
CYBERDYNE Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥212.00 |
| 52 Week High | JP¥327.00 |
| 52 Week Low | JP¥177.00 |
| Beta | 0 |
| 11 Month Change | 9.84% |
| 3 Month Change | -0.47% |
| 1 Year Change | -33.75% |
| 33 Year Change | -57.00% |
| 5 Year Change | -69.19% |
| Change since IPO | -77.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7779 | JP Medical Equipment | JP Market | |
|---|---|---|---|
| 7D | 0.5% | 2.3% | 2.9% |
| 1Y | -33.8% | 6.9% | 20.0% |
Return vs Industry: 7779 underperformed the JP Medical Equipment industry which returned 6.9% over the past year.
Return vs Market: 7779 underperformed the JP Market which returned 20% over the past year.
Price Volatility
| 7779 volatility | |
|---|---|
| 7779 Average Weekly Movement | 5.9% |
| Medical Equipment Industry Average Movement | 3.7% |
| Market Average Movement | 3.9% |
| 10% most volatile stocks in JP Market | 7.3% |
| 10% least volatile stocks in JP Market | 2.0% |
Stable Share Price: 7779 has not had significant price volatility in the past 3 months.
Volatility Over Time: 7779's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 227 | Yoshiyuki Sankai | www.cyberdyne.jp |
CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains equipment and systems for medical and warfare in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use in lower limb and single joint type; non-medical HAL for lower limb, single joint type, and lumbar type; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; and Acoustic X, a high-speed light pulse LED array light source that enables real time photoacoustic imaging. It also provides Cybernics Treatment, a treatment that uses HAL to enhance and regenerate the function of the wearer for spinal cord injury, stroke, neuromuscular diseases, etc.; Neuro HALFIT for enhancement of brain-nerve-musculoskeltal system; MTX Neuro HAL Plus to enhance the performance of the athletes’ brain-nerve functions; and Neuro HALFIT at home for enhancement of physical functions.
CYBERDYNE Inc. Fundamentals Summary
| 7779 fundamental statistics | |
|---|---|
| Market cap | JP¥44.76b |
| Earnings (TTM) | -JP¥1.48b |
| Revenue (TTM) | JP¥4.35b |
10.3x
P/S Ratio-30.3x
P/E RatioIs 7779 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7779 income statement (TTM) | |
|---|---|
| Revenue | JP¥4.35b |
| Cost of Revenue | JP¥1.96b |
| Gross Profit | JP¥2.39b |
| Other Expenses | JP¥3.87b |
| Earnings | -JP¥1.48b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 14, 2024
| Earnings per share (EPS) | -6.99 |
| Gross Margin | 54.96% |
| Net Profit Margin | -33.90% |
| Debt/Equity Ratio | 0.3% |
How did 7779 perform over the long term?
See historical performance and comparison